BioRestorative Therapies, Inc. (BRTX) stock
BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$1.32−0.02 (-1.12%)
Close on Nov 18, 2026Market cap $33.76MP/E –Yield –
BioRestorative Therapies revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
BioRestorative Therapies's revenue for the twelve months ending Mar 31, 2026 was $357.87K, down 8.5% year over year. For fiscal 2025 it was $359.70K, down 10.3% from the year before. Over ten years it grew -5.4% a year on average. The highest annual figure on record is $628.92K in fiscal 2015.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $359.70K | -10.3% |
| FY2024 | Dec 31, 2024 | $401.00K | +175.0% |
| FY2023 | Dec 31, 2023 | $145.80K | +21.7% |
| FY2022 | Dec 31, 2022 | $119.80K | +160.4% |
| FY2021 | Dec 31, 2021 | $46.00K | -40.3% |
| FY2020 | Dec 31, 2020 | $77.00K | -40.8% |
| FY2019 | Dec 31, 2019 | $130.00K | +17.1% |
| FY2018 | Dec 31, 2018 | $111.00K | +37.0% |
| FY2017 | Dec 31, 2017 | $81.00K | +122.8% |
| FY2016 | Dec 31, 2016 | $36.36K | -94.2% |
| FY2015 | Dec 31, 2015 | $628.92K | +51.2% |
| FY2014 | Dec 31, 2014 | $416.00K | +24661.7% |
| FY2013 | Dec 31, 2013 | $1.68K | -89.2% |
| FY2012 | Dec 31, 2012 | $15.59K | – |
| FY2011 | Dec 31, 2011 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | $23.17K | -7.3% |
| Q4 FY2025 | Dec 31, 2025 | $19.60K | -54.7% |
| Q3 FY2025 | Sep 30, 2025 | $11.80K | -94.9% |
| Q2 FY2025 | Jun 30, 2025 | $303.30K | +240.4% |
| Q1 FY2025 | Mar 31, 2025 | $25.00K | -28.6% |
| Q4 FY2024 | Dec 31, 2024 | $43.30K | +124.4% |
| Q3 FY2024 | Sep 30, 2024 | $233.60K | +660.9% |
| Q2 FY2024 | Jun 30, 2024 | $89.10K | +38.1% |
| Q1 FY2024 | Mar 31, 2024 | $35.00K | +11.8% |
| Q4 FY2023 | Dec 31, 2023 | $19.30K | +421.6% |
| Q3 FY2023 | Sep 30, 2023 | $30.70K | +5.9% |
| Q2 FY2023 | Jun 30, 2023 | $64.50K | -9.3% |
| Q1 FY2023 | Mar 31, 2023 | $31.30K | +95.6% |
| Q4 FY2022 | Dec 31, 2022 | $3.70K | -26.0% |
| Q3 FY2022 | Sep 30, 2022 | $29.00K | +262.5% |
| Q2 FY2022 | Jun 30, 2022 | $71.10K | +374.0% |
| Q1 FY2022 | Mar 31, 2022 | $16.00K | -11.1% |
| Q4 FY2021 | Dec 31, 2021 | $5.00K | -70.6% |
| Q3 FY2021 | Sep 30, 2021 | $8.00K | -46.7% |
| Q2 FY2021 | Jun 30, 2021 | $15.00K | -21.1% |
| Q1 FY2021 | Mar 31, 2021 | $18.00K | -30.8% |
| Q4 FY2020 | Dec 31, 2020 | $17.00K | -46.9% |
| Q3 FY2020 | Sep 30, 2020 | $15.00K | -60.5% |
| Q2 FY2020 | Jun 30, 2020 | $19.00K | -38.7% |
| Q1 FY2020 | Mar 31, 2020 | $26.00K | -10.3% |
| Q4 FY2019 | Dec 31, 2019 | $32.00K | +10.3% |
| Q3 FY2019 | Sep 30, 2019 | $38.00K | +46.2% |
| Q2 FY2019 | Jun 30, 2019 | $31.00K | -16.2% |
| Q1 FY2019 | Mar 31, 2019 | $29.00K | +52.6% |
| Q4 FY2018 | Dec 31, 2018 | $29.00K | -23.7% |
| Q3 FY2018 | Sep 30, 2018 | $26.00K | +62.5% |
| Q2 FY2018 | Jun 30, 2018 | $37.00K | +85.0% |
| Q1 FY2018 | Mar 31, 2018 | $19.00K | +171.4% |
| Q4 FY2017 | Dec 31, 2017 | $38.00K | +525.5% |
| Q3 FY2017 | Sep 30, 2017 | $16.00K | +220.0% |
| Q2 FY2017 | Jun 30, 2017 | $20.00K | +23.8% |
| Q1 FY2017 | Mar 31, 2017 | $7.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $6.08K | – |
| Q3 FY2016 | Sep 30, 2016 | $5.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $16.16K | – |
See a number that looks wrong?